STEAP2 acts as a tumor suppressor by inhibiting the Hedgehog signaling pathway and epithelial-to-mesenchymal transition (EMT), thereby reducing PTC cell proliferation, invasion, and migration. The gene discussed is STEAP2; the disease is neoplasm.